A share price of Maze Therapeutics Inc [MAZE] is currently trading at $14.27, up 2.88%. An important factor to consider is whether the stock is rising or falling in short-term value. The MAZE shares have gain 7.86% over the last week, with a monthly amount drifted -7.94%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Maze Therapeutics Inc [NASDAQ: MAZE] stock has seen the most recent analyst activity on July 23, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $34. Previously, Wedbush started tracking the stock with Outperform rating on July 08, 2025, and set its price target to $17.
Maze Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $6.71 and $19.19. Currently, Wall Street analysts expect the stock to reach $17 within the next 12 months. Maze Therapeutics Inc [NASDAQ: MAZE] shares were valued at $14.27 at the most recent close of the market. An investor can expect a potential return of 19.13% based on the average MAZE price forecast.
Analyzing the MAZE fundamentals
Gross Profit Margin for this corporation currently stands at 0.18% with Operating Profit Margin at -50.33%, Pretax Profit Margin comes in at -48.54%, and Net Profit Margin reading is -48.32%. To continue investigating profitability, this company’s Return on Assets is posted at -0.4, Equity is 11.67 and Total Capital is -0.44. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 13.90 points at the first support level, and at 13.53 for the second support level. However, for the 1st resistance point, the stock is sitting at 14.52, and for the 2nd resistance point, it is at 14.76.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Maze Therapeutics Inc [NASDAQ:MAZE] is 13.63. On the other hand, the Quick Ratio is 13.63, and the Cash Ratio is 13.29. Considering the valuation of this stock, the price to sales ratio is 250.30, the price to book ratio is 2.39.
